Health-Related Quality of Life in Non-Small Cell Lung Cancer (NSCLC) Patients with Mutation of Epidermal Growth Factor Receptor (EGFR) in Indonesia

Seftika Sari; Tri Murti Andayani; Dwi Endarti; Kartika Widayati

doi:10.5958/0974-360X.2020.00086.4

Research Journal of Pharmacy and Technology

ISSN

0974-360X (Online)
0974-3618 (Print)

Submit Article

Health-Related Quality of Life in Non-Small Cell Lung Cancer (NSCLC) Patients with Mutation of Epidermal Growth Factor Receptor (EGFR) in Indonesia

Author(s): Seftika Sari, Tri Murti Andayani, Dwi Endarti, Kartika Widayati

Email(s): trimutia@yahoo.com

DOI: 10.5958/0974-360X.2020.00086.4

Address: Seftika Sari1,2, Tri Murti Andayani3*, Dwi Endarti4, Kartika Widayati5
1Doctoral Program in Pharmaceutical Science, Faculty of Pharmacy, Universitas Gadjah Mada, Yogyakarta, Indonesia
2Sekolah Tinggi Ilmu Farmasi Riau, Pekanbaru, Indonesia
3Department of Pharmacology and Clinical Pharmacy, Faculty of Pharmacy, Gadjah Mada University, Yogyakarta, Indonesia
4Department of Pharmaceutics, Faculty of Pharmacy, Gadjah Mada University, Yogyakarta, Indonesia
5Department of Internal Medicine, Division of Hematology and Medical Oncology, Faculty of Medicine Gadjah Mada University-Dr. Sardjito Hospital, Yogyakarta, Indonesia.
*Corresponding Author

Published In: Volume - 13, Issue - 1, Year - 2020

Keywords:

Cite this article:
Seftika Sari, Tri Murti Andayani, Dwi Endarti, Kartika Widayati. Health-Related Quality of Life in Non-Small Cell Lung Cancer (NSCLC) Patients with Mutation of Epidermal Growth Factor Receptor (EGFR) in Indonesia. Research J. Pharm. and Tech. 2020; 13(1):443-447. doi: 10.5958/0974-360X.2020.00086.4

View PDF